Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mélanie Hinterlang1, Mona Assefi2, Pauline Glasman3

  • 1Pharm. D., Unité REQPHARM, pharmacie à usage intérieur, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France.

The Canadian Journal of Hospital Pharmacy
|December 4, 2025
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Effect of Restrictive vs Liberal Blood Transfusion Strategy on Subsequent Myocardial Infarction Type.

JACC. Advances·2026
Same author

Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial.

Circulation·2026
Same author

Discomfort of noninvasive ventilation, high flow nasal cannula oxygen, and conventional oxygen implemented after extubation in non-COPD patients.

Critical care (London, England)·2026
Same author

Impacts of stent characteristics on periprocedural ischemic events in elective PCI: the ALPHEUS-stents study.

International journal of cardiology·2026
Same author

Definition and Prediction of Periprocedural Myocardial Infarction in Elective Percutaneous Coronary Intervention: The ALPHEUS-MI Study.

The Canadian journal of cardiology·2026
Same author

Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial.

JAMA cardiology·2026
This summary is machine-generated.

Controlling experimental drug dispensing in critical care clinical trials is vital. A risk assessment identified communication as a key area for improvement, leading to proposed corrective measures to enhance patient safety and research efficiency.

Area of Science:

  • Critical care medicine
  • Clinical pharmacology
  • Risk management in healthcare
Keywords:
and criticality analysis (FMECA)critical careeffectsexperimental drugfailure modesrisksafety

Related Experiment Videos